The table below shows BioNexus Gene Lab Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$22.84K
$2.54M
$2.26M
$2.14M
$2.63M
$1.97M
Cost of revenue
$23.63K
$2.17M
$1.89M
$1.79M
$2.30M
$1.69M
Gross profit
-$790.00
$377.69K
$368.02K
$343.49K
$326.54K
$288.72K
R&D
$14.49K
$14.88K
$12.56K
$12.14K
$10.44K
$8.20K
BGLC annual revenue (10-K history)
BioNexus Gene Lab Corp reported annual revenue of $7.42M for fiscal year 2025. That is down 21.9% from $9.51M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $212.33K (FY 2018) to $7.42M. Figures come from the company's audited annual reports as filed with the SEC.